WASHINGTON, Jan 20 (Reuters) - U.S. pharmaceutical company Moderna expects to announce where it will set up a "fill-finish" facility for COVID-19 vaccine production in Africa in the next month or so, its chief legal officer, Shannon Klinger said on Thursday.

Klinger told a virtual event hosted by the Financial Times that the pharmaceutical industry had initially been slow in getting vaccines to Africa, but Moderna now was taking steps to change the situation.

"In terms of timing, we can do fill-finish on the continent as early as next year, and are in active discussions with respect to that. We hope to announce our country of choice in the next month or so," she said.

(Reporting by Andrea Shalal; Editing by Chizu Nomiyama)